All Type of News
KFDA urged strictly to abide KGMP provisions
The KFDA strongly urged the relevant authorities to keep thorough cares with caution over the quality controls of drugs in all stages starting from the inventory coming in and out, to dispensing and medication process...
Cancer drugs: Phase II clinical studies enough for registration.
The KFDA may approve the product registration for anti-cancer drugs only with the phase II clinical study data to speed up the drug development and help cancer patients to get an appropriate treatment utmost timely, a...
Anti-smoking supplements contributed to business diversification.
Many different and diversified types of anti-smoking preparations have been launched into the market since the early of this year when the nationwide no-smoking campaign bursted out.
It is suggested that the pharm...
Belt-tightening management in domestic pharmaceutical industry is looming
Influenced by the sudden pharmaceutical business downturn in the latter half of this year and uncertain business outlook next year, a growing number of domestic pharmaceutical firms are adopting the restructuring prog...
License system of drugs with improved formulation, etc. to be reformed
The Korea Food and Administration (KFDA) has announced that the conventional license system of drug with improved formulation, etc. will be reformed so as to expedite the development of new drugs and promote the domes...
KFDA to approve in vitro diagnostics as OTCs
The KFDA plans to switch in vitro diagnostics into OTCs in a bid to foster a biotechnology industry and protect the consumers.
Noting that since a majority of self-test kits are classified into prescription drugs e...
Gioyoung to operate it full-fledged distribution business from this December
Gioyoung has secured several drug distribution warehouses to jointly purchase the combined drugs of 62 pharmaceutical firms from next month.
Gioyoung said that the drug distribution business would be operated by 14...
Bone mineral density level < 3 SD below normal should be lowered
Pharmaceutical business sources say that with the increasing number of osteoporosis patients in the recent years, the current insurance system for osteoporosis drugs should be changed.
The domestic market for osteo...
Drug prices unavoidable to cut down.
The pharmacy communities are extremely alert to which the Health Insurance Policy Council cut down the relative value points directly causing the current pharmacist's dispensing fees to reduce.
The MOHW earlier a...
KFDA to draft approval of protocol on drug
The approval for revision of a clinical trial protocol on drug will be simplified and new drugs for clinical trial purpose may be administered to patients to a terminal-phase cancer and AIDS prior to market authorizat...
